cardiologists, internal medicine physicians, emergency room clinicians, and other health care professionals involved in the treatment of ACS
Myocardial Infarction, Thrombosis, Anticoagulant Therapy
DISCLOSURE POLICY STATEMENT
The Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners. Disclosures will be made known to the participants prior to the activity.
The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.
The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Stephen D. Wiviott, MD, FACC: Consultant: Daiichi-Sankyo, Eli Lilly, ICON, Johnson & Johnson, St. Jude Medical; Research: AstraZeneca, Eisai, Merck
Dominick J. Angiolillo, MD, PhD: Advisory Board: Abbott Vascular, AstraZeneca, Bristol-Myers Squibb/Sanofi-Aventis, Eli Lilly/Daiichi-Sankyo, The Medicines Company, Merck; Data Safety Monitoring Board: Johnson & Johnson, St. Jude Medical, Sunovion; Research: AstraZeneca, Daiichi-Sankyo, Eli Lilly, Esther and King Biomedical Research, Evolva, Gilead, Johnson & Johnson, The Medicines Company; Speaker: AstraZeneca, Daiichi-Sankyo, Eli Lilly, Merck
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Barry Watkins, PhD; Blair St. Amand; Jay Katz, CCMEP; Laurie Muldowney, MD:
Nothing to disclose
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, the post-test, or evaluation, please email firstname.lastname@example.org.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This continuing medical education activity is jointly provided by the Potomac Center for Medical Education and Rockpointe.
This program is supported through an educational grant from Daiichi-Sankyo, Inc. and Lilly USA, LLC.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.0 AMA PRA category 1 credits™. Statement of credit will be available to print from your user history page.
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above